Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist
- 15 December 1995
- journal article
- conference paper
- Published by Elsevier in Behavioural Brain Research
- Vol. 73 (1-2), 163-167
- https://doi.org/10.1016/0166-4328(96)00090-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the ratEuropean Journal of Pharmacology, 1995
- Blockade of Striatal 5‐Hydroxytryptmine2 Receptors Reduces the Increase in Extracellullar Concentrations of Dopamine Produced by the Amphhetamine analogue 3,4‐MethylenedioxymethamphetamineJournal of Neurochemistry, 1994
- D-Amphetamine-like stimulus properties are produced by morphine injections into the ventral tegmental area but not into the nucleus accumbensBehavioural Brain Research, 1993
- MDL 73,147EF, a 5-HT3 antagonist, facilitates latent inhibition in the ratPharmacology Biochemistry and Behavior, 1992
- The effect of 5-HT3 receptor antagonists on the discriminative stimulus effects of amphetamineEuropean Journal of Pharmacology, 1992
- The neuropsychology of schizophreniaBehavioral and Brain Sciences, 1991
- Amphetamine-like stimulus properties produced by electrical stimulation of reward sites in the ventral tegmental areaBehavioural Brain Research, 1990
- 6‐Hydroxydopamine lesions of the nucleus accumbens attenuate the discriminative stimulus effects of d‐amphetamineDrug Development Research, 1989
- Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatumBrain Research, 1975